In recent years, there has been increased interest in the mechanisms involved in anaesthetic-induced cardioprotection. It is not thoroughly understood how volatile anaesthetics protect the myocardium from ischaemia or reperfusion injury, but the overall mechanism is likely to be multifactorial. This review examines the recent experimental and clinical research underlying the cellular and molecular mechanisms involved in anaesthetic-induced preconditioning.
Many therapeutic approaches in the perioperative period of patients with coronary artery disease are required to improve outcome and reduce postoperative complications. New treatment approaches focus on reducing the incidence of perioperative myocardial ischaemia and/or reperfusion injury, both of which may lead to irreversible myocardial damage.
Ischaemic preconditioning, first described in 1986 by Murry et al 1 , is the exposure of myocardial tissue to multiple brief, repeated periods of ischaemia, thereby providing cardioprotection during a subsequent sustained period of ischaemia and/or reperfusion injury. In recent years, similar to ischaemic preconditioning, the potentially beneficial effects of anaesthetic-induced preconditioning (APC) 2 have been proposed as one of the strategies available for myocardial protection in both cardiac and non-cardiac surgery. Volatile APC can be provided throughout the operative period and can also be administered via the ventilator via the oxygenator during cardiopulmonary bypass. APC has been reported to reduce myocardial damage and myocardial infarct size, and to improve ventricular systolic and diastolic functions in the setting of myocardial ischaemia or/and reperfusion injury 3, 4 .
Although the mechanisms of their protective effects have not been fully elucidated, there has been extensive research in this area recently. A better understanding of the mechanisms involved in APC may provide anaesthetists with strategies to reduce the incidence of perioperative cardiac ischaemia and/or reperfusion injuries. This review focuses on the potential mechanisms that contribute to volatile APC.
METHODS
Articles concerning volatile APC were obtained from Google Scholar, Ovid, Elsevier and Medline databases (1966 to November 2008). The language of articles was limited to English. Inclusion and exclusion criteria were as follows: terms "anaesthetics", "preconditioning", "ischaemia" and "reperfusion" were crossed, and the terms "volatile", "intravenous", "myocardium" "opioids" and "mechanism" were crossed in order to minimise irrelevant findings. We included primary research papers that investigated any aspect relating to the mechanism of APC and excluded articles with incomplete methods or data. Duplicate studies were also removed as well as studies unrelated to volatile APC. A total of 62 papers are finally included in the review.
MECHANISMS INVOLVED IN APC
In APC, volatile anaesthetics appear to mediate their protection in cardiomyocytes by selectively priming sarcolemmal and mitochondrial adenosinetriphosphate-sensitive potassium channels through triggering a complex signal cascade involving protein kinase C, protein tyrosine kinase, second messenger signal systems such as guanine nucleotide-binding proteins and by the influence on Ca 2+ homeostasis and the generation of reactive oxygen species or nitric oxide (NO) through parallel pathways. Figure 1 illustrates the possible signal transduction pathways and factors involved in APC.
Adenosine-triphosphate-sensitive potassium channels
Adenosine-triphosphate-sensitive potassium channels (K ATP channels), coupling with energy metabolism for cell activity, serve a unique cellular function among signal transduction cascades. K ATP channels have been proposed to be end-effectors of preconditioning and the opening of K ATP channels may finally lead to depolarisation of the mitochondrial membrane.
Two types of K ATP channels are located in cardiac myocytes, including the mitochondrial (mitoK ATP ) channel and the sarcolemmal (sarcK ATP ) channel. It has been suggested that the beneficial effects of ischaemic preconditioning on infarct volume and stunning may be exerted via separately activating mitoK ATP and sarcK ATP channels 5 . Many researchers have confirmed that K ATP channels are a key element in mediating APC with the use of K ATP channel blockers in a number of animal models and experimental conditions. Although the opening of both mitoK ATP and sarcK ATP channels are considered to be the major step in the preconditioning cascade, there is considerable controversy about their importance. The modulation of sarcK ATP channels has been reported to contribute to the APC whether by isoflurane 6 or halothane 7 . In contrast, sevoflurane 8 has been found to activate mitoK ATP channels in APC. Similar effects were also found in opioid agonists: the activation of mitoK ATP channel results in the preconditioning-like effect of morphine in a concentration-dependent manner in a cardiac myocyte model of simulated ischaemia 9 and mitoK ATP channel activation also causes delayed cardioprotective effect of a δ1-opioid receptor agonist TAN-67 10 . Furthermore, other results indicate that volatile anaesthetics may not directly open mitoK ATP channels, but prime mitoK ATP channel activity through multiple protein kinase C (PKC)coupled signalling pathways in a model of isolated rat ventricular myocytes 11 . In comparison, although studies regarding the K ATP channels in human myocardial preconditioning are limited, sporadic studies have noted a significant effect of K ATP channel involvement in the process of APC. Desflurane was reported to exert its preconditioning effect against simulated ischaemia through the activation of mitoK ATP channels in isolated human right atria myocardium in vitro 12 . SarcK ATP and mitoK ATP channels were both found to be involved in the desflurane-induced cardioprotective effect 13 . Tonkovic-Capin et al 14 also concluded that both channels contributed to isoflurane-induced delayed cardio-protection in neonatal rabbits. The interrelations between both channels have been explained in diverse published articles.
Nitric oxide
Nitric oxide, first characterised as an endotheliumderived relaxation factor, mediated APC as an unique bioactive signalling messenger in target cells despite the involvement of other signalling messengers or ion channels. Nitric oxide synthase (NOS) triggers and mediates the release and formation of NO in association with a preconditioning stimulus.
With the increase of biosynthesis of NO via enhanced NOS activity and the activation of PKC in the myocardium during brief ischaemia and reperfusion periods, NO radicals and their metabolites were associated with the cardioprotective effects. NOS (nNOS, eNOS, iNOS), distributed in myocytes, plays a dual role, either acting as the trigger or mediator in isoflurane-induced cardioprotection 15 . Not only was early desflurane-induced preconditioning blocked by NOS inhibitor l-NA 16 , but the administration of the NO scavenger PTIO or the NOS inhibitors L-NAME and L-NIL also inhibited protection afforded by sevoflurane 17 . Meanwhile, sevoflurane also increased NO release and improved coronary vascular function after global ischaemia in isolated guinea-pig hearts 18 . Nevertheless, the eNOS-cGMP pathway was not affected by several concentrations of halothane, isoflurane or sevoflurane in crystalloid perfused guinea-pig hearts 19 .
Guanine nucleotide-binding proteins
Guanine nucleotide-binding proteins (G proteins) are the important second messengers among various signalling pathways. Preconditioning causes the activation of various receptors (adenosine A1 receptors, opioid receptors and bradykinin receptors) and the generation of other free radicals, which then transmit signals via G proteins, which lead to the formation of inositol triphosphate, production of diacylglycerol and cause the activation of protein kinases, phosphorylation of ADP and the enhancement of K ATP channel opening.
The cardioprotective effects of ischaemic preconditioning could be inhibited by pertussis toxin (Gi protein blocker) 20, 21 . The observation that Gi protein inhibition may completely block APC 22, 23 supports the concept that G proteins contribute to the transmission and amplification of the preconditioning stimulus in signal-transduction pathways. However, other results showed an inhibitory effect of halothane on Gi proteins in human myocardium 24 and supportive research further revealed that volatile anaesthetics including halothane, isoflurane and enflurane in clinical concentrations may also inhibit G protein-coupled inwardly rectifying potassium channels 25 . These diverse results may be correlated with some sideeffect of volatile anaesthetics. For opioids, research showed that the δ1-opioid receptor elicited a cardioprotective effect mediated via G i/o proteins 26 and selective activation of δ1-opioid agonists may exert the cardioprotection by interaction with Gi proteins and activation of PKC 27 . Although experiments have confirmed the importance of the mediation by G proteins in preconditioning, further research is required to elucidate their precise roles in the signal transduction pathways.
Ca 2+ homeostasis
During both ischaemic and anaesthetic preconditioning, the homeostasis of Ca 2+ contributes directly to myocardial function.
Prolonged ischaemia and reperfusion have been shown to induce lethal myocardial injury by the increase of mitochondrial and cytosolic Ca 2+ overload, resulting in the impairment of energy production and subsequent cellular ATP depletion 28 . However, with the pretreatment by volatile anaesthetics, sequences of events were able to be triggered to protect the heart by reducing Ca 2+ loading. Isoflurane, sevoflurane and halothane have already been shown to suppress sarcoplasmic reticulum Ca 2+ release and depress myofilament Ca 2+ sensitivity in rat ventricular myocytes 29 and in ferret cardiac muscle 30 . In addition, in guineapig isolated hearts, sevoflurane pretreatment was found to consistently improve cardiac function by reducing Ca 2+ loading and improving myocardial Ca 2+ responsiveness 31 . Moreover, strong evidence supports the cardioprotective effect of clinically relevant doses of halothane and isoflurane, which decreases Ca 2+ sensitivity and suppressed maximal Ca 2+ activated tension production in human skinned cardiac fibres 32 .
The relationships between Ca 2+ loading and other signalling pathways in APC have led to the hypothesis that the moderation of the opening of K ATP channels may result in the maintenance of intracellular and/or mitochondrial Ca 2+ homeostasis 33 . Although there has been little investigation into the cardioprotective effects of intravenous anaesthetics such as ketamine and benzodiazepines, propofol has been shown to demonstrate some cardioprotective effects 34 , possibly by affecting sarcoplasmic reticulum Ca 2+ handling 35 .
Protein kinases
Preconditioning results from a complex signal conduction, including the activation of multiple kinases, whose translocation and phosphorylation in the parallel signalling pathways may underlie the mechanism of protection against ischaemia and reperfusion injury.
The PKC family has been implicated as a key signalling component upstream of the closely associated mitoK ATP channel. The cellular signal is passed from G proteins to K ATP channels through the activation of PKC. In APC, volatile anaesthetics may exert their protection by selectively priming the opening of mitoK ATP channels through translocation of PKC isoforms to trigger PKCcoupled signalling pathways. Isoflurane induced selective translocation of PKC-δ to mitochondria and nuclei, and PKC-ε to sarcolemmal membranes, nuclei and intercalated disks in rat myocardium 36 . However, owing to experimental discrepancies, these results were in contrast to other data, as isoflurane induced the translocation of PKC-δ and PKC-ε to sarcolemmal and mitochondrial membranes 37 . In addition, PKC-δ 38 and PKC-ε 39 isozymes have also been shown to be mediators to modulate the opening of sarcK ATP channels in isoflurane-induced preconditioning. Experiments on human myocardium have shown that the translocation of PKC-δ and PKC-ε also occurred in response to sevofluraneinduced anaesthetic preconditioning 40 .
Protein tyrosine kinases (PTK) and mitogenactivated protein kinases (MAPK) are other important additional or alternative signalling elements of the signal transduction cascade responsible for APC. SarcPTK has been found to mediate isoflurane-induced preconditioning in the intact rat heart 36 . However, contrary reports showed that desflurane-induced preconditioning did not depend on tyrosine kinase activation when using two structurally different PTK blocking agents genistein and lavendustin A in the rabbit heart in vivo 41 . ERK1/2, subfamily of MAPK, was the mediator in APC 42 and triggered isoflurane preconditioning with upregulation of hypoxiainducible factor 1α and vascular endothelial growth factor expression in rats 43 . With the stimulation of the delta(1)-opioid receptor, another 44-kDa isoform of ERK in the cytoplasm stimulated the cardioprotection 44 . Similarly, the activation of opioid agonists exerts cardioprotection via activation of PKC, PTK and ultimately K ATP channels. Fentanyl was found to enhance mitoK ATP channel activity 45 and reduce infarction by the mediation of PKC 46 . These observations provide the rational deduction that anaesthetics exert cardioprotective effects via multiple intracellular kinases, although precise involvement of certain kinases deserves further investigation.
Reactive oxygen species
Reactive oxygen species (ROS), involved in the signalling cascade for cardioprotection induced by brief exposure to a volatile anaesthetic, are regarded as an essential component of cardiac anaesthetic preconditioning.
Large quantities of ROS released during reperfusion after coronary artery occlusion may cause tissue injury due to their effect on intracellular homeostasis 47 . In contrast, small amounts of ROS may exert beneficial effects during ischaemia 48 . Volatile anaesthetics are able to modulate the release of deleterious quantities of ROS associated with coronary artery occlusion and reperfusion. For example, isoflurane reduced hydroxyl radical production in the ischaemic rat heart 49 and the administration of the ROS scavengers NAC, 2-MPG 23 , MPG and MnTBAP 50 abolished the attenuation of myocardial infarction in isofluraneinduced preconditioning in rabbit models.
ROS demonstrate cardioprotective effects as triggers of anaesthetic preconditioning in isolated guinea pig hearts 17 . They modulated PKC function directly via oxidative modification or indirectly via tyrosine phosphorylation 51, 52 . Meanwhile, the translocation of PKC-δ 53 and the activation of MAPK 54 may act as the key element downstream of ROS. The relationship between the mitoK ATP channel and ROS is not sufficiently clear; whether volatile anaesthetic-induced mitoK ATP channel opening precedes or follows ROS generation still remains controversial. Some reports indicated that ROS modulated mitoK ATP channel activity acts as a trigger of APC and that mitoK ATP channels can be directly activated by ROS 55 , while another report demonstrated that ROS was the end-effector following the activation of mitoK ATP 56 .
DISCUSSION
There is now sufficient experimental evidence to demonstrate that pretreatment with volatile anaesthetics exerts cardioprotective effects via a mechanism similar to that of ischaemic preconditioning. It is assumed that stepwise or parallel signal cascades contribute to the major potential mechanisms of their cardioprotective phenomena as shown in Figure 1 .
Volatile anaesthetics partition in plasma membranes and closely interact with key signalling molecules. The initial signal is passed from second messengers to subcellular targets such as nuclei and mitochondria at the initiation of ischaemia through different signal transduction cascades. Volatile anaesthetics, by interacting with receptors through G proteins, induce the activation of protein kinases. The activation and opening of K ATP channels after phosphorylation of protein kinases allows potassium inflow in the mitochondria, which results in an increase in matrix volume and regulation of mitochondrial volume 57 . The stimulation of K ATP channels causes an increase in ROS formation, which further activates protein kinases, leading to key protein phosphorylation. ROS may also serve as a trigger to induce the opening of mitoK ATP channels, which subsequently generate additional ROS required for preconditioning. Intracellular calcium homeostasis acts inside the cell to mediate the activation of K ATP channels.
Different partitioning of volatile anaesthetics at interfaces, as well as different experimental approaches and species differences, might differentiate their cytoprotective effects. There are few discrepancies of the protective properties among volatile anaesthetics that have been definitely confirmed. While differences have been reported, results have not defined which anaesthetic has superior protection 58, 59 . In addition, protection by intravenous anaesthetics against ischaemia and/or reperfusion injury has also been demonstrated during the last few years. There is no evidence that has suggested significant differences among intravenous anaesthetics as yet. Intravenous anaesthetics may activate receptors to stimulate the downstream signal transduction pathways for amplification and establishment of the preconditioned state. Moreover, rather than mimicking ischaemic preconditioning, intravenous anaesthetics may exert a direct protective effect on cardiac tissues against ischaemia and/or reperfusion injury by attenuating Ca 2+ 35 and decreasing neutrophil adhesion and transmigration 60 . The protective difference between volatile and intravenous anaesthetics varies greatly. Infarcts in rabbits anaesthetised with halothane, enflurane and isoflurane were about one half as large as those in pentobarbitone, ketamine-xylazine or propofol groups 61 . In contrast, infarct size in preconditioned rabbits was shown to have no significant difference among pentobarbitone, isoflurane and ketamine/ xylazine 62 . Therefore, precise determination of the mechanisms needs to consider different experimental protocols as well as species and anaesthetic chosen.
In summary, a variety of intracellular signalling pathways have been implicated in APC. A more thorough understanding of the multiple signalling steps and the ultimate cytoprotective mechanisms underlying APC may lead to improvements in the management of ischaemia and/or reperfusion injury.
